Comparative Serum Estradiol Profiles from a New Once-a-Week Transdermal Estradiol Patch and a Twice-a-Week Transdermal Estradiol Patch

Authors:
  • DRDianna J. Riedel
    Dianna J. Riedel
  • SCShaw F. Chang
    Shaw F. Chang
  • JJJoseph P. Jacobson
    Joseph P. Jacobson
  • JSJudy A. Sellers
    Judy A. Sellers
  • CKCharlene M. Kanniainen
    Charlene M. Kanniainen
  • JCJan K. Crowley
    Jan K. Crowley
  • PHPeter H. Hinderling
    Peter H. Hinderling

Abstract
Two identical open-label, randomized crossover studies were conducted to compare serum estradiol profiles from the new 12.5- and 25-cm2 once-a-week adhesive patches with those from the 10- and 20-cm2 commercially available twice-a-week Estraderm patches when applied as directed during a 1-week patch-wear period. Both studies were conducted in healthy postmenopausal women; serum estradiol levels were determined by gas chromatography/mass spectroscopy (GC/MS). Although both sizes of both patch treatments produced mean serum estradiol levels in the therapeutic range, the once-a-week patch provided more constant mean levels, avoiding large peak-to-trough fluctuations. As expected, the differences in mean serum estradiol concentrations between the two patch treatments occurred during the second application of the twice-a-week patch. Based on these results, the once-a-week drug in adhesive patch appears to be an acceptable means of hormone replacement therapy.

This publication has 7 references indexed in Scilit: